1. The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes
- Author
-
Daniel J Kearns, Mark Little, Phil Boardman, Tina Mackinnon, Jeremy Crew, Ruth MacPherson, Charles R Tapping, and Andrew Macdonald
- Subjects
Male ,medicine.medical_specialty ,animal structures ,Prostatic Hyperplasia ,Urology ,urologic and male genital diseases ,030218 nuclear medicine & medical imaging ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Refractory ,Prostate ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Prospective Studies ,Prospective cohort study ,Aged ,Aged, 80 and over ,business.industry ,Ultrasound ,Arteries ,Middle Aged ,Hyperplasia ,medicine.disease ,Embolization, Therapeutic ,Magnetic Resonance Imaging ,Prostatic artery embolization ,Treatment Outcome ,medicine.anatomical_structure ,Radiological weapon ,Quality of Life ,Cardiology and Cardiovascular Medicine ,business - Abstract
To establish factors predictive of success prior to Prostate Artery Embolization (PAE) with MRI imaging. A prospective cohort study of 50 patients with Benign Prostatic Hyperplasia (BPH) were treated with PAE in a single institution. Patients had moderate to severe symptoms of BPH refractory to medical management for at least 6 months. Patients were imaged with multiparametric MRI imaging pre-PAE and at 3 months, 12 months and 24 months post-PAE. Clinical success was measured with IPSS, IIEF and EQ-5D-5L quality of life questionnaires. The technical success was 48/50 (96%).The mean age of the group was 67 (range 54โ83). The mean IPSS score pre-PAE was 21 and at 24 months was 8 (p
- Published
- 2020